Globus Medical, Inc.'s stock has surged due to a successful execution of the NuVasive deal and three consecutive guidance hikes, boosting investor confidence and valuation. The $3.1 billion ...
JMP Securities analyst David Turkaly has reiterated their neutral stance on GMED stock, giving a Hold rating on November 11. David Turkaly has ...
Globus Medical, Inc.'s ( NYSE:GMED ) recent soft profit numbers didn't appear to worry shareholders, as the stock ...
Globus Medical (GMED) is one such stock that our proprietary system currently recommends. The company not only has a favorable Growth Score, but also carries a top Zacks Rank.
Audubon, PA-based Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its ...
Globus Medical Inc. (NYSE:GMED), a leading player in the musculoskeletal healthcare sector, has been making waves in the medical device industry with its innovative robotic surgery platforms and ...
Globus Medical Inc. (NYSE:GMED), a leading player in the musculoskeletal healthcare sector, has been making waves in the medical device industry with its innovative robotic surgery platforms and ...